CHOC doctors discover the possible efficacy of treating PCS with the GI device IB-Stim. A clinical trial is underway.
Medical device research leads to improved neonatal care
A partnership between CHOC and Masimo has developed technology to noninvasively monitor blood oxygen and hemoglobin levels in newborns.
Rare disease leaders to speak at inaugural symposium and family conference on March 11
The Inaugural CHOC and UCI Rare Disease Symposium & Family Conference will take place on Friday, March 11, 2022, from 10:30 a.m. to 3 p.m.
Enzyme replacement therapy slows progression of CLN2 Disease
CHOC is at the forefront to offer breakthrough enzyme replacement therapy to improve the quality of life for children with CLN2.
Virtual psychosocial support improves adolescent and young adult oncology outcomes during pandemic
When the pandemic hit, CHOC’s psychosocial programs for adolescents and young adults with cancer went virtual but brought new opportunities.
Quality improvement effort reduces chronic lung disease in preterm infants
After years of research, CHOC implemented advanced protocols that could produce a distinct reduction in chronic lung disease in infants.
